Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Management of antiepileptic treatment after epilepsy surgery - practices and problems

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The role of antiplatelet therapy in primary prevention. A review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hyperpolarized (13)C MR Angiography

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Old, New and Hidden Causes of Perioperative Hypersensitivity

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Why are antiepileptic drugs continued after successful epilepsy surgery in adults?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Children with dyskinetic cerebral palsy are severely affected as compared to bilateral spastic cerebral palsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Psychogenic nonepileptic seizures treated with psychotherapy: Long-term outcome on seizures and healthcare utilization

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Declining malformation rates with changed antiepileptic drug prescribing: An observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Although epilepsy surgery is a recognized treatment option for drug-resistant epilepsies since several decades, the management of antiepileptic drugs (AEDs) after successful surgery still remains one of the most difficult and unsolved therapeutic challenges. Indeed, no systematic controlled trials have been specifically conducted so far and no consensus or standardized guidelines regarding postsurgical drug discontinuation policy and procedures are available.

METHODS: In this paper, we aim to provide an updated overview on the the present knowledge on this topic, which is based mainly on retrospective studies reporting practices used in individual centers.

RESULTS: Currently available data suggest that: 1) rate of seizure recurrence appears to be higher in patients undergoing early (before 6 months or 9 months according to different studies) AED withdrawal; 2) seizures that recur during AED tapering are easier to control than unprovoked postoperative seizure relapses; 3) there is no evidence to support negative long-term implications on seizure outcomes in patients who attempted AED withdrawal. In the pediatric age group, shorter intervals from surgery to AED reduction and to complete AED discontinuation predict seizure relapse during or after AED reduction/withdrawal. However, this does not correlate with the chances of regaining seizure freedom after drug reintroduction.

CONCLUSION: Carefully conducted prospective longitudinal studies and randomized controlled trials are warranted to establish the correct post-surgical pharmacologic treatment and to identify the best candidates for AEDs discontinuation.

OriginalsprogEngelsk
TidsskriftCurrent Pharmaceutical Design
Vol/bind23
Udgave nummer37
Sider (fra-til)5749-5759
ISSN1381-6128
DOI
StatusUdgivet - 2017

ID: 52170305